Cargando…
COVID-19 vaccine development from the perspective of cancer patients
Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patient...
Autores principales: | He, Yang, Ding, Yi, Cao, Bo, Huang, Yi, Wang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437497/ https://www.ncbi.nlm.nih.gov/pubmed/34170788 http://dx.doi.org/10.1080/21645515.2021.1943988 |
Ejemplares similares
-
Landscape and progress of global COVID-19 vaccine development
por: Huang, Hui-Yao, et al.
Publicado: (2021) -
Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review
por: Yeo, Suji, et al.
Publicado: (2023) -
Recombinant vaccines for COVID-19
por: Yadav, Tushar, et al.
Publicado: (2020) -
Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020) -
Recent advances in vaccine and immunotherapy for COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2020)